TrialBridge - GlobalTrialBridge.com

What I built. TrialBridge is a two-sided clinical-trial feasibility layer for Brazil, built entirely with Claude Code — by a founder who has never written a line of code. A sponsor pastes a ClinicalTrials.gov protocol; Claude parses the eligibility criteria into typed rules with its reasoning shown for every criterion; a direct-standardized estimator turns 163GB of public DataSUS data into state-by-state eligible-population estimates with 95% confidence intervals, rendered as an interactive Brazil map and a ranked site shortlist. Sites answer feasibility privately — no patient record ever leaves their walls. It's live, deployed, access-gated, and ships as an MCP server so the same query can be asked inside Claude. What I found. Two findings. A hackathon survey (N=50, run via Claude + Prolific over MCP) showed 70% of pharma/biotech buyers had never heard of Brazil's Lei 14.874/2024, and one paragraph about it lifted their intent to run trials there by +1.39 points (p<.001). And our own calibration harness found the model calibrates near-perfectly in-distribution but breaks across hospital sites — a limit we report openly. Why it matters. Trials are running out of patients where they've always run. Brazil has 214M people, a new law that cut approval from >12 months to ~90 business days, and costs up to 75% lower — but the market is pricing it on outdated information. TrialBridge closes that gap with provable numbers, at the feasibility stage where the decision is actually made.